Discovering smoking-related pathway alterations in urothelial cell carcinoma pathogenesis

Affiliations

Comment

Guido Martignoni. Cell Cycle. 2013.

. 2013 May 15;12(10):1483.

doi: 10.4161/cc.24852. Epub 2013 Apr 29.

¹ Department of Pathology and Diagnostics, University of Verona, Verona, Italy. guidomart@yahoo.com

No abstract available

Keywords: bladder cancer; epigenetics; in vitro transformation; pathogenesis; smoking.

Comment on

Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
Brait M, Munari E, LeBron C, Noordhuis MG, Begum S, Michailidi C, Gonzalez-Roibon N, Maldonado L, Sen T, Guerrero-Preston R, Cope L, Parrella P, Fazio VM, Ha PK, Netto GJ, Sidransky D, Hoque MO. Brait M, et al. Cell Cycle. 2013 Apr 1;12(7):1058-70. doi: 10.4161/cc.24050. Epub 2013 Feb 22. Cell Cycle. 2013. PMID: 23435205 Free PMC article.

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi: 10.3322/caac.20138. - DOI - PubMed
1. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89:630–9. doi: 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q. - DOI - PubMed
1. Dalbagni G, Parekh DJ, Ben-Porat L, Potenzoni M, Herr HW, Reuter VE. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder. BJU Int. 2007;99:281–5. doi: 10.1111/j.1464-410X.2006.06624.x. - DOI - PubMed
1. Netto GJ. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol. 2012;9:41–51. doi: 10.1038/nrurol.2011.193. - DOI - PubMed
1. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, et al. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2786–94. doi: 10.1158/1055-9965.EPI-08-0192. - DOI - PMC - PubMed